Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-)

被引:37
作者
Li, TY [1 ]
Xue, YQ [1 ]
Wu, YF [1 ]
Pan, JL [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Haematol, Suzhou 215006, Peoples R China
关键词
myeloid disease; isochromosome; deletion of 20q; fluorescence in situ hybridization; prognosis;
D O I
10.1111/j.1365-2141.2004.04921.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report on seven patients with myeloid diseases characterized by i(20q-) anomaly. Four patients were male and three were female, their median age was 57 years. The diagnosis at presentation was myelodysplastic syndrome in six patients, acute myeloid leukaemia in one patient. Four died but three survived and remain anaemic. The survivals were 6 months for patient 1, 7 months for patient 2, 17 d for patient 4 and 28 d for patient 5. Chromosome specimens were prepared by direct and/or short-term culture of bone marrow cells. Karyotype analysis was performed by R- and G-banding technique, which showed that one of the normal chromosomes 20 was substituted by one or two small metacentric chromosomes in all seven patients. The karyotype was ider(20)(q10)del(20)(q11q13), i.e. i(20q-) in six patients by dual-colour fluorescence in situ hybridization assay using two probes (a subtelomeric probe for 20q and an unique probe for 20q12). As far as we know, this anomaly has not been reported previously. Thus, we consider that i(20q-) is a novel and rare recurrent chromosomal abnormality that is specifically associated with myeloid diseases and may indicate a poor prognosis.
引用
收藏
页码:337 / 342
页数:6
相关论文
共 17 条
  • [1] Asimakopoulos FA, 1996, BRIT J HAEMATOL, V95, P219
  • [2] Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes
    Bench, AJ
    Nacheva, EP
    Hood, TL
    Holden, JL
    French, L
    Swanton, S
    Champion, KM
    Li, J
    Whittaker, P
    Stavrides, G
    Hunt, AR
    Huntly, BJP
    Campbell, LJ
    Bentley, DR
    Deloukas, P
    Green, AR
    [J]. ONCOGENE, 2000, 19 (34) : 3902 - 3913
  • [3] DAVIS F, 1984, AM EDUC, V20, P12
  • [4] DEMORY JL, 1988, BLOOD, V72, P855
  • [5] PRESENCE OF ISOCHROMOSOMES IN HEMATOLOGIC DISEASES
    DEVINUESA, ML
    SLAVUTSKY, I
    LARRIPA, I
    [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 25 (01) : 47 - 54
  • [6] CHROMOSOME-STUDIES IN 104 PATIENTS WITH POLYCYTHEMIA-VERA
    DIEZMARTIN, JL
    GRAHAM, DL
    PETITT, RM
    DEWALD, GW
    [J]. MAYO CLINIC PROCEEDINGS, 1991, 66 (03) : 287 - 299
  • [7] Identification of multiple copies of a 20q-chromosome in a case of myelodysplastic syndrome: a FISH study
    Falzetti, D
    Vermeesch, JR
    Hood, TL
    Nacheva, EP
    Matteucci, C
    Martelli, MF
    Van den Berghe, H
    Marynen, P
    Mecucci, C
    [J]. LEUKEMIA RESEARCH, 1999, 23 (04) : 407 - 413
  • [8] International scoring system for evaluating prognosis in myelodysplastic syndromes
    Greenberg, P
    Cox, C
    LeBeau, MM
    Fenaux, P
    Morel, P
    Sanz, G
    Sanz, M
    Vallespi, T
    Hamblin, T
    Oscier, D
    Ohyashiki, K
    Toyama, K
    Aul, C
    Mufti, G
    Bennett, J
    [J]. BLOOD, 1997, 89 (06) : 2079 - 2088
  • [9] HEIM S, 1992, CANCER, V70, P1701, DOI 10.1002/1097-0142(19920915)70:4+<1701::AID-CNCR2820701609>3.0.CO
  • [10] 2-S